Par Drugs and Chemicals Limited share price
NSE: PAR · ISIN INE04LG01015
Key numbers
- Market cap
- ₹ 162 Cr
- Current price
- ₹ 131.41
- 52-week high / low
- ₹ 180 / 78
- Stock P/E
- 12.3
- Book value
- ₹ 90.5
- Dividend yield
- 0.00%
- ROCE
- 16.4%
- ROE
- 12.4%
- Debt to equity
- 0.00
- Sales growth (3 yrs)
- 2.6%
- Profit growth (3 yrs)
- 5.0%
- 1-year return
- 16.9%
About Par Drugs and Chemicals Limited
Par Drugs and Chemicals Limited develops, manufactures, and sells active pharmaceutical ingredients (APIs) and fine chemicals in India. The company provides API products, including magnesium hydroxide, magnesium oxide USP, sucralfate, almagate BP, dried aluminium hydroxide gel, light magnesium carbonate, magaldrate, magnesium trisilicate, colloidal silicon dioxide, aluminium magnesium silicate, magnesium aluminometasilicate, magnesium aluminosilicate-USP, magnesium oxide light, magnesium oxide heavy, magnesium aluminium hydrate, hydrotalcite, and synthetic aluminium silicate. It offers fine chemicals, such as precipitated silica, sodium aluminium silicate, amorphous aluminium hydroxide, Alusil, PARSIL-HT, aluminium hydroxide magnesium carbonate co-dried gel, magnesium aluminium silicate hydrated (pharma), and magnesium aluminium silicate hydrated (agro). Par Drugs and Chemicals Limited was founded in 1982 and is based in Vadodara, India.
Quarterly results
Consolidated figures in ₹ crores
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | |
|---|---|---|---|---|---|
| Sales | 22 | 26 | 29 | 29 | 20 |
| Operating profit | 2 | 4 | 6 | 6 | 1 |
| Net profit | 2 | 3 | 4 | 5 | 1 |
| EPS (₹) | 1.34 | 2.70 | 3.36 | 3.90 | 0.69 |
Peers in Drug Manufacturers - Specialty & Generic
Data for information only, not investment advice. Prices end of day.